Verification of the lactate threshold obtained from sweat measuring device for patients with heart failure
- Conditions
- Heart FailureD006333
- Registration Number
- JPRN-jRCT2032220057
- Lead Sponsor
- Katsumata Yoshinori
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
(1) Patients who can voluntarily obtain consent to participate in the clinical trial in writing from the patient.
(2) Men and women aged between 20 and 90 at the time of consent and suffering from New York Heart Association functional classification (NYHA) I or II heart failure.
(3) Patients planning to receive exercise therapy.
(1) Patients with severe skin diseases.
(2) Patients with lacerations at the device application site.
(3) Patients with extremely low sweating (confirmed by interview).
(4) Patients who are judged by the investigator, etc. to be inappropriate for this clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method